FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161528077> ?p ?o ?g. }

• W2161528077 endingPage "563" @default.
• W2161528077 startingPage "556" @default.
• W2161528077 abstract "Stereotactic body radiation therapy (SBRT) has been proposed for the palliation of painful vertebral bone metastases because higher radiation doses may result in superior and more durable pain control. A phase III clinical trial (Radiation Therapy Oncology Group 0631) comparing single fraction SBRT with single fraction external beam radiation therapy (EBRT) in palliative treatment of painful vertebral bone metastases is now ongoing. We performed a cost-effectiveness analysis to compare these strategies.A Markov model, using a 1-month cycle over a lifetime horizon, was developed to compare the cost-effectiveness of SBRT (16 or 18 Gy in 1 fraction) with that of 8 Gy in 1 fraction of EBRT. Transition probabilities, quality of life utilities, and costs associated with SBRT and EBRT were captured in the model. Costs were based on Medicare reimbursement in 2014. Strategies were compared using the incremental cost-effectiveness ratio (ICER), and effectiveness was measured in quality-adjusted life years (QALYs). To account for uncertainty, 1-way, 2-way and probabilistic sensitivity analyses were performed. Strategies were evaluated with a willingness-to-pay (WTP) threshold of $100,000 per QALY gained.Base case pain relief after the treatment was assumed as 20% higher in SBRT. Base case treatment costs for SBRT and EBRT were $9000 and $1087, respectively. In the base case analysis, SBRT resulted in an ICER of $124,552 per QALY gained. In 1-way sensitivity analyses, results were most sensitive to variation of the utility of unrelieved pain; the utility of relieved pain after initial treatment and median survival were also sensitive to variation. If median survival is ≥11 months, SBRT cost <$100,000 per QALY gained.SBRT for palliation of vertebral bone metastases is not cost-effective compared with EBRT at a $100,000 per QALY gained WTP threshold. However, if median survival is ≥11 months, SBRT costs ≤$100,000 per QALY gained, suggesting that selective SBRT use in patients with longer expected survival may be the most cost-effective approach." @default.
• W2161528077 created "2016-06-24" @default.
• W2161528077 creator A5012533343 @default.
• W2161528077 creator A5015602896 @default.
• W2161528077 creator A5020805128 @default.
• W2161528077 creator A5023468026 @default.
• W2161528077 creator A5075658285 @default.
• W2161528077 date "2015-03-01" @default.
• W2161528077 modified "2023-10-14" @default.
• W2161528077 title "Cost-Effectiveness Analysis of Single Fraction of Stereotactic Body Radiation Therapy Compared With Single Fraction of External Beam Radiation Therapy for Palliation of Vertebral Bone Metastases" @default.
• W2161528077 cites W1608460440 @default.
• W2161528077 cites W1823223265 @default.
• W2161528077 cites W1861968676 @default.
• W2161528077 cites W1971280286 @default.
• W2161528077 cites W1980238474 @default.
• W2161528077 cites W1983945206 @default.
• W2161528077 cites W1988227247 @default.
• W2161528077 cites W1989374984 @default.
• W2161528077 cites W1991576090 @default.
• W2161528077 cites W1992625706 @default.
• W2161528077 cites W1994561005 @default.
• W2161528077 cites W2005638449 @default.
• W2161528077 cites W2007917978 @default.
• W2161528077 cites W2011000634 @default.
• W2161528077 cites W2018038855 @default.
• W2161528077 cites W2019582591 @default.
• W2161528077 cites W2022242364 @default.
• W2161528077 cites W2032876335 @default.
• W2161528077 cites W2038229428 @default.
• W2161528077 cites W2083624286 @default.
• W2161528077 cites W2095629759 @default.
• W2161528077 cites W2096929608 @default.
• W2161528077 cites W2099818867 @default.
• W2161528077 cites W2100625706 @default.
• W2161528077 cites W2113235727 @default.
• W2161528077 cites W2134047636 @default.
• W2161528077 cites W2137241566 @default.
• W2161528077 cites W2138156952 @default.
• W2161528077 cites W2156880958 @default.
• W2161528077 cites W2166870452 @default.
• W2161528077 cites W2170595359 @default.
• W2161528077 cites W4229694820 @default.
• W2161528077 doi "https://doi.org/10.1016/j.ijrobp.2014.10.055" @default.
• W2161528077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25680599" @default.
• W2161528077 hasPublicationYear "2015" @default.
• W2161528077 type Work @default.
• W2161528077 sameAs 2161528077 @default.
• W2161528077 citedByCount "40" @default.
• W2161528077 countsByYear W21615280772015 @default.
• W2161528077 countsByYear W21615280772016 @default.
• W2161528077 countsByYear W21615280772017 @default.
• W2161528077 countsByYear W21615280772018 @default.
• W2161528077 countsByYear W21615280772019 @default.
• W2161528077 countsByYear W21615280772020 @default.
• W2161528077 countsByYear W21615280772021 @default.
• W2161528077 countsByYear W21615280772022 @default.
• W2161528077 countsByYear W21615280772023 @default.
• W2161528077 crossrefType "journal-article" @default.
• W2161528077 hasAuthorship W2161528077A5012533343 @default.
• W2161528077 hasAuthorship W2161528077A5015602896 @default.
• W2161528077 hasAuthorship W2161528077A5020805128 @default.
• W2161528077 hasAuthorship W2161528077A5023468026 @default.
• W2161528077 hasAuthorship W2161528077A5075658285 @default.
• W2161528077 hasConcept C112930515 @default.
• W2161528077 hasConcept C126838900 @default.
• W2161528077 hasConcept C141071460 @default.
• W2161528077 hasConcept C159110408 @default.
• W2161528077 hasConcept C160735492 @default.
• W2161528077 hasConcept C162324750 @default.
• W2161528077 hasConcept C2779703844 @default.
• W2161528077 hasConcept C2779951463 @default.
• W2161528077 hasConcept C2780387249 @default.
• W2161528077 hasConcept C2989005 @default.
• W2161528077 hasConcept C3019080777 @default.
• W2161528077 hasConcept C50522688 @default.
• W2161528077 hasConcept C509974204 @default.
• W2161528077 hasConcept C71924100 @default.
• W2161528077 hasConceptScore W2161528077C112930515 @default.
• W2161528077 hasConceptScore W2161528077C126838900 @default.
• W2161528077 hasConceptScore W2161528077C141071460 @default.
• W2161528077 hasConceptScore W2161528077C159110408 @default.
• W2161528077 hasConceptScore W2161528077C160735492 @default.
• W2161528077 hasConceptScore W2161528077C162324750 @default.
• W2161528077 hasConceptScore W2161528077C2779703844 @default.
• W2161528077 hasConceptScore W2161528077C2779951463 @default.
• W2161528077 hasConceptScore W2161528077C2780387249 @default.
• W2161528077 hasConceptScore W2161528077C2989005 @default.
• W2161528077 hasConceptScore W2161528077C3019080777 @default.
• W2161528077 hasConceptScore W2161528077C50522688 @default.
• W2161528077 hasConceptScore W2161528077C509974204 @default.
• W2161528077 hasConceptScore W2161528077C71924100 @default.
• W2161528077 hasIssue "3" @default.
• W2161528077 hasLocation W21615280771 @default.
• W2161528077 hasLocation W21615280772 @default.
• W2161528077 hasOpenAccess W2161528077 @default.
• W2161528077 hasPrimaryLocation W21615280771 @default.
• W2161528077 hasRelatedWork W2002120878 @default.
• W2161528077 hasRelatedWork W2003938723 @default.

• next